全文获取类型
收费全文 | 2064篇 |
免费 | 184篇 |
国内免费 | 29篇 |
专业分类
耳鼻咽喉 | 6篇 |
儿科学 | 82篇 |
妇产科学 | 41篇 |
基础医学 | 286篇 |
口腔科学 | 62篇 |
临床医学 | 259篇 |
内科学 | 445篇 |
皮肤病学 | 15篇 |
神经病学 | 191篇 |
特种医学 | 265篇 |
外科学 | 193篇 |
综合类 | 73篇 |
一般理论 | 2篇 |
预防医学 | 157篇 |
眼科学 | 58篇 |
药学 | 79篇 |
1篇 | |
肿瘤学 | 62篇 |
出版年
2021年 | 21篇 |
2019年 | 15篇 |
2018年 | 32篇 |
2017年 | 18篇 |
2016年 | 15篇 |
2015年 | 23篇 |
2014年 | 36篇 |
2013年 | 58篇 |
2012年 | 48篇 |
2011年 | 69篇 |
2010年 | 64篇 |
2009年 | 43篇 |
2008年 | 60篇 |
2007年 | 81篇 |
2006年 | 61篇 |
2005年 | 50篇 |
2004年 | 42篇 |
2003年 | 49篇 |
2002年 | 34篇 |
2001年 | 37篇 |
2000年 | 42篇 |
1999年 | 57篇 |
1998年 | 76篇 |
1997年 | 80篇 |
1996年 | 87篇 |
1995年 | 62篇 |
1994年 | 49篇 |
1993年 | 54篇 |
1992年 | 46篇 |
1991年 | 38篇 |
1990年 | 50篇 |
1989年 | 60篇 |
1988年 | 71篇 |
1987年 | 52篇 |
1986年 | 76篇 |
1985年 | 69篇 |
1984年 | 23篇 |
1983年 | 30篇 |
1982年 | 24篇 |
1981年 | 29篇 |
1980年 | 25篇 |
1979年 | 30篇 |
1978年 | 22篇 |
1977年 | 39篇 |
1976年 | 33篇 |
1975年 | 22篇 |
1974年 | 20篇 |
1973年 | 20篇 |
1972年 | 20篇 |
1970年 | 30篇 |
排序方式: 共有2277条查询结果,搜索用时 15 毫秒
1.
Isolated patellofemoral arthritis is an increasingly recognized entity, and is usually associated with previous patellofemoral dysplasia or instability. Patellofemoral arthroplasty (PFA) has evolved significantly in recent years, both in terms of implant design and importantly in the understanding of appropriate patient selection. This review outlines the indications and investigations for PFA, provides a brief history of the development of contemporary implants, and presents the clinical outcomes for the prostheses most commonly used in the UK. In addition, it provides a detailed surgical technique for implantation of an onlay implant, with tips on how to optimize patellofemoral biomechanics and thus achieve a consistently good outcome. 相似文献
2.
3.
Sonoelasticity imaging of prostate cancer: in vitro results 总被引:2,自引:0,他引:2
4.
D F Levinson 《Clinical therapeutics》1991,13(3):326-352
The literature on the pharmacologic treatment of schizophrenia and schizoaffective disorders is reviewed (116 references). All clinically active antipsychotic drugs share the ability to block postsynaptic dopamine receptors in the central nervous system. Their potencies vary, chlorpromazine and thioridazine being the least potent and fluphenazine and haloperidol the most potent. The adverse effects of the neuroleptics include acute dystonia, parkinsonian symptoms (extrapyramidal symptoms), akathisia, tardive dyskinesia, and tardive dystonia. When used at equipotent doses, all classic neuroleptics now available are equally effective in the treatment of schizophrenia. Choice of drug is based on adverse effects and patient response. The neuroleptics are effective in most acute exacerbations of schizophrenia and for the prevention or mitigation of relapse. Their effects are more pronounced on the positive symptoms of schizophrenia, such as hallucinations, delusions, disordered thinking, and paranoia, than on the negative symptoms, such as deficits in social interaction, emotional expression, and motivation. Strategies for acute and maintenance treatment and for the management of treatment-resistant patients are reviewed. The pharmacology and clinical use of the newer atypical neuroleptics, particularly clozapine, and their adverse effects are discussed. 相似文献
5.
6.
7.
8.
9.
10.
G M Simpson K G Yadalam D F Levinson M J Stephanos E S Lo T B Cooper 《Journal of clinical psychopharmacology》1990,10(6):417-421
Fluphenazine decanoate is commonly used as part of maintenance treatment of schizophrenia, but its pharmacokinetics are poorly understood. We administered a single intramuscular dose of fluphenazine decanoate to nine patients and found that plasma fluphenazine level did not decline to 50% of the peak level by day 26 in any of the patients. This means that it has a long half-life measurable in months rather than weeks. 相似文献